Here are the stocks that are in news today:
Results Today: Orchid Pharma, Huhtamaki PPL, Firstsource Solutions
January Trade Deficit at USD 15.17 billion, Imports at USD 41.14 billion & Exports at USD 25.97 billion
Granules India: USFDA completes inspection at company’s Hyderabad unit with 2 observations
Cipla gets USFDA nod for Deferasirox - CNBC-TV18
Alkem Labs gets USFDA nod for Hypertension Drug Chlorthalidon - CNBC-TV18
Dr Reddy's Laboratories - USFDA determines Duvvada’s formulations manufacturing unit as voluntary action initiated (VAI)
RITES emerges as successful bidder for supply of locomotives, coaches worth Rs 680 crore
Hero MotoCorp launches BS-VI Splendor+, price starting Rs 59,600
Dr Reddy's: US FDA completes audit of Srikakulum plant, with zero observation
Zydus Cadila launches a fast tracked programme to develop vaccine for the novel coronavirus, 2019-nCoV (COVID-19)
PNC Infratech - Credit Analysis & Research Limited (CARE) assigned CARE AA; Stable rating to subsidiary, PNC Raebareli Highways, long term bank facilities of Rs 490.89 crore
Punjab & Sind Bank revised the Marginal Cost of Fund Based Lending Rate (MCLR) for different tenors effective from 16.02.2020
Indiabulls Housing Finance - CARE Ratings has revised the long-term rating to “CARE AA” with Stable outlook
Lupin launches bacterial conjunctivitis drug Moxifloxacin Ophthalmic solution
SAIL Q3: Consolidated net loss at Rs 343.6 crore versus profit at Rs 638.8 crore, revenue up 4.4 percent at Rs 16,542.5 crore versus Rs 15,842.2 crore, YoY
Glenmark Pharma Q3: Consolidated net profit up 64.1 percent at Rs 190.8 crore versus Rs 116.3 crore, revenue up 7.1 percent at Rs 2,735.5 crore versus Rs 2,555 crore, YoY
ONGC Q3: Net profit down 33.7 percent at Rs 4,151.6 crore versus Rs 6,263.1 crore, revenue down 3.2 percent at Rs 23,710 crore versus Rs 24,492.6 crore, QoQ
Sun TV Q3: Net profit up 6.3 percent at Rs 373.5 crore versus Rs 351 crore, revenue down 9.9 percent at Rs 815 crore versus Rs 904 crore, YoY
SREI Infra Q3: Consolidated net Profit down 34.4 percent at Rs 60.03 crore versus Rs 91.56 crore, revenue down 10.03 percent at Rs 1,450.5 crore versus Rs 1,617.5 crore
IRB Infra Q3: Net profit down 27 percent at Rs 159.7 crore versus Rs 218.9 crore, revenue down 2.6 percent at Rs 1,742.6 crore versus Rs 1,788.5 crore, YoY
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!